BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3761355)

  • 21. Lymphocyte subpopulations in Crohn's disease and chronic ulcerative colitis.
    Sorensen SF; Hoj L
    Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):41-8. PubMed ID: 320824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary allergy evaluated by PRIST and RAST in inflammatory bowel disease.
    Brignola C; Miniero R; Campieri M; Bazzocchi G; Vegetti S; Farruggia P; Lanfranchi GA
    Hepatogastroenterology; 1986 Jun; 33(3):128-30. PubMed ID: 3744282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
    Yantiss RK; Odze RD
    Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of proliferating cell nuclear antigen (PCNA) expression and intraepithelial lymphocyte count in the differential diagnosis of inflammatory bowel disease.
    Keller K; Koch HK
    Ital J Gastroenterol; 1994 Jun; 26(5):233-7. PubMed ID: 7919464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
    J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis].
    Boirivant M; Marini M; Di Felice G
    Ann Ist Super Sanita; 1999; 35(2):283-9. PubMed ID: 10645662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine production in inflammatory bowel disease.
    Miura M; Hiwatashi N
    J Clin Lab Immunol; 1985 Oct; 18(2):81-6. PubMed ID: 3908685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraepithelial lymphocyte eotaxin-2 expression and perineural mast cell degranulation differentiate allergic/eosinophilic colitis from classic IBD.
    Torrente F; Barabino A; Bellini T; Murch SH
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):300-7. PubMed ID: 24813533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Microerosions' in rectal biopsies in Crohn's disease.
    Poulsen SS; Pedersen NT; Jarnum S
    Scand J Gastroenterol; 1984 Jul; 19(5):607-12. PubMed ID: 6474082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies.
    Makiyama K; Selby WS; Jewell DP
    Clin Exp Immunol; 1983 May; 52(2):350-4. PubMed ID: 6602677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum IgE levels in patients with inflammatory bowel disease.
    Levo Y; Shalit M; Wollner S; Fich A
    Ann Allergy; 1986 Jan; 56(1):85-7. PubMed ID: 3946842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte migration inhibitory factor (LMIF) release by human colonic lymphocytes.
    Bartnik W; ReMine SG; Shorter RG
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):397-405. PubMed ID: 6271090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
    Schmitz-Moormann P; Himmelmann GW; Brandes JW
    Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease.
    Noguchi M; Hiwatashi N; Liu Z; Toyota T
    J Gastroenterol; 1995 Nov; 30 Suppl 8():52-5. PubMed ID: 8563891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.